FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094156977> ?p ?o ?g. }

• W2094156977 endingPage "477" @default.
• W2094156977 startingPage "469" @default.
• W2094156977 abstract "While allogeneic bone marrow transplantation (BMT) has long been known to be capable of inducing donor-specific tolerance and hence permitting allograft acceptance without immunosuppressive pharmacotherapy, the toxicity of conditioning regimens required to achieve marrow engraftment has precluded the application of this approach to clinical organ transplantation. A relatively nontoxic method of conditioning mice that allows allogeneic bone marrow engraftment and induction of donor-specific skin allograft tolerance has recently been described. This regimen included anti-CD4 and anti-CD8 mAbs administered on day -5, followed by 3-Gy whole body irradiation (WBI) and 7-Gy thymic irradiation (TI) on day 0. To further reduce the potential toxicity of this regimen, we have now attempted to overcome the requirement for TI by administering additional mAb injections before and after BMT. Mixed chimerism and prolonged donor-specific skin graft acceptance were induced in 90% of B10 mice conditioned with anti-CD4 and -CD8 mAbs on days -6 and -1 and 3-Gy WBI on day 0 without TI. Despite long-term acceptance of donor-specific skin grafts, however, some of these animals showed a gradual decline in donor-type hematopoietic repopulation, and 2 of 10 mice regrafted with a second donor-type skin graft 5-9 months after BMT rejected the second and/or the original graft. This rejection after repeat donor-specific skin grafting correlated with a decline in the percentage of donor-type T cells between 6 and 12 weeks after BMT. In contrast, all animals receiving additional mAb injections 7 and 14 days following BMT after conditioning with mAbs on days -6 and -1 and 3-Gy WBI showed stable chimerism and accepted both primary and secondary donor-specific skin grafts. Animals receiving TI in addition to mAb and 3-Gy WBI also showed stable chimerism and long-term acceptance of initial (at 7 weeks) and later repeat donor-specific grafts. In contrast, the majority of mice receiving mAbs only on day -5 or on day -1 only, followed by 3-Gy WBI on day 0 without TI, did not accept initial donor-specific skin grafts, and showed only transient chimerism. Thus, the requirement for thymic irradiation to allow permanent mixed chimerism and donor-specific tolerance induction can be overcome by the administration of additional T cell-depleting mAb injections. These results establish a less toxic method of inducing donor-specific tolerance, thus increasing the potential clinical applicability of this approach to inducing organ allograft acceptance without chronic immunosuppressive therapy." @default.
• W2094156977 created "2016-06-24" @default.
• W2094156977 creator A5019400914 @default.
• W2094156977 creator A5039315558 @default.
• W2094156977 creator A5061151796 @default.
• W2094156977 creator A5073338357 @default.
• W2094156977 date "1996-02-01" @default.
• W2094156977 modified "2023-09-23" @default.
• W2094156977 title "ADDITIONAL MONOCLONAL ANTIBODY (mAB) INJECTIONS CAN REPLACE THYMIC IRRADIATION TO ALLOW INDUCTION OF MIXED CHIMERISM AND TOLERANCE IN MICE RECEIVING BONE MARROW TRANSPLANTATION AFTER CONDITIONING WITH ANTI-T CELL mABs AND 3-GY WHOLE BODY IRRADIATION1" @default.
• W2094156977 cites W11344094 @default.
• W2094156977 cites W1967702267 @default.
• W2094156977 cites W2008083688 @default.
• W2094156977 cites W2014229420 @default.
• W2094156977 cites W2024604633 @default.
• W2094156977 cites W2028183411 @default.
• W2094156977 cites W2028537846 @default.
• W2094156977 cites W2036276239 @default.
• W2094156977 cites W2050959380 @default.
• W2094156977 cites W2058796077 @default.
• W2094156977 cites W2086594545 @default.
• W2094156977 cites W2095016279 @default.
• W2094156977 cites W2110272001 @default.
• W2094156977 cites W2121964181 @default.
• W2094156977 cites W2124971003 @default.
• W2094156977 cites W2150841203 @default.
• W2094156977 cites W2156895470 @default.
• W2094156977 cites W2165835604 @default.
• W2094156977 cites W2412941035 @default.
• W2094156977 cites W4322388287 @default.
• W2094156977 doi "https://doi.org/10.1097/00007890-199602150-00027" @default.
• W2094156977 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8610363" @default.
• W2094156977 hasPublicationYear "1996" @default.
• W2094156977 type Work @default.
• W2094156977 sameAs 2094156977 @default.
• W2094156977 citedByCount "125" @default.
• W2094156977 countsByYear W20941569772012 @default.
• W2094156977 countsByYear W20941569772013 @default.
• W2094156977 countsByYear W20941569772014 @default.
• W2094156977 countsByYear W20941569772015 @default.
• W2094156977 countsByYear W20941569772016 @default.
• W2094156977 countsByYear W20941569772017 @default.
• W2094156977 countsByYear W20941569772018 @default.
• W2094156977 countsByYear W20941569772019 @default.
• W2094156977 countsByYear W20941569772022 @default.
• W2094156977 countsByYear W20941569772023 @default.
• W2094156977 crossrefType "journal-article" @default.
• W2094156977 hasAuthorship W2094156977A5019400914 @default.
• W2094156977 hasAuthorship W2094156977A5039315558 @default.
• W2094156977 hasAuthorship W2094156977A5061151796 @default.
• W2094156977 hasAuthorship W2094156977A5073338357 @default.
• W2094156977 hasBestOaLocation W20941569771 @default.
• W2094156977 hasConcept C109159458 @default.
• W2094156977 hasConcept C141071460 @default.
• W2094156977 hasConcept C159654299 @default.
• W2094156977 hasConcept C167672396 @default.
• W2094156977 hasConcept C203014093 @default.
• W2094156977 hasConcept C2776694085 @default.
• W2094156977 hasConcept C2776755627 @default.
• W2094156977 hasConcept C2778880498 @default.
• W2094156977 hasConcept C2780007613 @default.
• W2094156977 hasConcept C28328180 @default.
• W2094156977 hasConcept C2911091166 @default.
• W2094156977 hasConcept C542903549 @default.
• W2094156977 hasConcept C54355233 @default.
• W2094156977 hasConcept C71924100 @default.
• W2094156977 hasConcept C86803240 @default.
• W2094156977 hasConcept C8891405 @default.
• W2094156977 hasConceptScore W2094156977C109159458 @default.
• W2094156977 hasConceptScore W2094156977C141071460 @default.
• W2094156977 hasConceptScore W2094156977C159654299 @default.
• W2094156977 hasConceptScore W2094156977C167672396 @default.
• W2094156977 hasConceptScore W2094156977C203014093 @default.
• W2094156977 hasConceptScore W2094156977C2776694085 @default.
• W2094156977 hasConceptScore W2094156977C2776755627 @default.
• W2094156977 hasConceptScore W2094156977C2778880498 @default.
• W2094156977 hasConceptScore W2094156977C2780007613 @default.
• W2094156977 hasConceptScore W2094156977C28328180 @default.
• W2094156977 hasConceptScore W2094156977C2911091166 @default.
• W2094156977 hasConceptScore W2094156977C542903549 @default.
• W2094156977 hasConceptScore W2094156977C54355233 @default.
• W2094156977 hasConceptScore W2094156977C71924100 @default.
• W2094156977 hasConceptScore W2094156977C86803240 @default.
• W2094156977 hasConceptScore W2094156977C8891405 @default.
• W2094156977 hasIssue "3" @default.
• W2094156977 hasLocation W20941569771 @default.
• W2094156977 hasLocation W20941569772 @default.
• W2094156977 hasLocation W20941569773 @default.
• W2094156977 hasOpenAccess W2094156977 @default.
• W2094156977 hasPrimaryLocation W20941569771 @default.
• W2094156977 hasRelatedWork W1970048706 @default.
• W2094156977 hasRelatedWork W1978598034 @default.
• W2094156977 hasRelatedWork W2029065458 @default.
• W2094156977 hasRelatedWork W2035629708 @default.
• W2094156977 hasRelatedWork W2078951023 @default.
• W2094156977 hasRelatedWork W2253242983 @default.
• W2094156977 hasRelatedWork W2314522894 @default.
• W2094156977 hasRelatedWork W2412102303 @default.
• W2094156977 hasRelatedWork W2979970396 @default.

• next